Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Theodore Friedman
Introduction
Theodore Friedman is a notable inventor based in La Jolla, California. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on utilizing genetic modification to enhance the immune response against tumors.
Latest Patents
Friedman holds a patent for "Lymphokine gene therapy of cancer." This novel method of tumor immunotherapy involves the genetic modification of cells to secrete cytokine gene products, which stimulate a patient's immune response to tumor antigens. In one embodiment, autologous fibroblasts are genetically modified to secrete at least one cytokine gene product, which is then used to immunize the patient alongside tumor antigens at a site other than an active tumor site. In another embodiment, cells are genetically modified to express at least one tumor antigen gene product and to secrete at least one cytokine gene product, also utilized for immunization at a non-active tumor site. This innovative approach has the potential to significantly improve cancer treatment outcomes.
Career Highlights
Friedman is associated with the Sidney Kimmel Cancer Center, where he conducts his research and develops his innovative therapies. His work has garnered attention for its potential to revolutionize cancer immunotherapy.
Collaborations
Some of his notable coworkers include Robert E. Sobol and Fred Harrison Gage. Their collaborative efforts contribute to advancing research in cancer treatment and immunotherapy.
Conclusion
Theodore Friedman is a pioneering inventor whose work in lymphokine gene therapy represents a significant advancement in cancer treatment. His innovative methods have the potential to enhance the effectiveness of immunotherapy, offering hope for improved patient outcomes.